CoLucid Pharmaceuticals' Series B Round

CoLucid Pharmaceuticals raised a round of funding on July 24, 2008.

CoLucid Pharmaceuticals (NASDAQ: CLCD) aims to advance drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's pipeline includes lasmiditan, a trea…

Articles about CoLucid Pharmaceuticals' Series B Round: